-
1
-
-
0034748416
-
Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation
-
Kanda Y, Mineishi S, Saito T, et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28 (7): 689-692.
-
(2001)
Bone Marrow Transplant
, vol.28
, Issue.7
, pp. 689-692
-
-
Kanda, Y.1
Mineishi, S.2
Saito, T.3
-
2
-
-
0035873217
-
A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation
-
Offidani M, Corvatta L, Olivieri A, et al. A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation. Clin Infect Dis 2001; 32 (10): 1414-1422.
-
(2001)
Clin Infect Dis
, vol.32
, Issue.10
, pp. 1414-1422
-
-
Offidani, M.1
Corvatta, L.2
Olivieri, A.3
-
3
-
-
62749111502
-
Herpes zoster (shingles) and postherpetic neuralgia
-
Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc 2009; 84 (3): 274-280.
-
(2009)
Mayo Clin Proc
, vol.84
, Issue.3
, pp. 274-280
-
-
Sampathkumar, P.1
Drage, L.A.2
Martin, D.P.3
-
4
-
-
0024414777
-
Herpes zoster infection after autologous bone marrow transplantation
-
Shuchter LM, Wingard JR, Piantadosi S, Burns WH, Santos GW, Saral R. Herpes zoster infection after autologous bone marrow transplantation. Blood 1989; 74 (4): 1424-1427.
-
(1989)
Blood
, vol.74
, Issue.4
, pp. 1424-1427
-
-
Shuchter, L.M.1
Wingard, J.R.2
Piantadosi, S.3
Burns, W.H.4
Santos, G.W.5
Saral, R.6
-
5
-
-
79953211185
-
High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation
-
Oct 25 [Epub ahead of print].
-
Su SH, Martel-Laferrière V, Labbé A, et al. High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010 Oct 25 [Epub ahead of print].
-
(2010)
Biol Blood Marrow Transplant
-
-
Su, S.H.1
Martel-Laferrière, V.2
Labbé, A.3
-
6
-
-
80053600672
-
-
National Comprehensive Cancer Network Inc. Prevention and treatment of cancer-related infections, version 1.2011. Available at Accessed 2011 May 9.
-
National Comprehensive Cancer Network Inc. Prevention and treatment of cancer-related infections, version 1.2011. Available at Accessed 2011 May 9.
-
-
-
-
7
-
-
84921537511
-
Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
-
Dykewicz CA, Jaffe HW, Kaplan JE, et al. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000; 49: 1-125.
-
(2000)
MMWR Recomm Rep.
, vol.49
, pp. 1-125
-
-
Dykewicz, C.A.1
Jaffe, H.W.2
Kaplan, J.E.3
-
8
-
-
69849102119
-
Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective
-
Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15 (10): 1143-1238.
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, Issue.10
, pp. 1143-1238
-
-
Tomblyn, M.1
Chiller, T.2
Einsele, H.3
-
9
-
-
35548939933
-
One year acyclovir prophylaxis for preventing varicella zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation
-
Erard V, Guthrie KA, Varley C, et al. One year acyclovir prophylaxis for preventing varicella zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood 2007; 110 (8): 3071-3077.
-
(2007)
Blood
, vol.110
, Issue.8
, pp. 3071-3077
-
-
Erard, V.1
Guthrie, K.A.2
Varley, C.3
-
10
-
-
85027928908
-
A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT
-
Klein A, Miller KB, Sprague K, DesJardin JA, Snydman DR. A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT. Bone Marrow Transplant 2011; 46 (2): 294-299.
-
(2011)
Bone Marrow Transplant
, vol.46
, Issue.2
, pp. 294-299
-
-
Klein, A.1
Miller, K.B.2
Sprague, K.3
DesJardin, J.A.4
Snydman, D.R.5
|